Business Wire Odonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2019 Provided by Business Wire Nov 6, 2019 1:20 PM UTC
Business Wire Odonate Therapeutics Announces Completion of Enrollment in CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer Provided by Business Wire Oct 21, 2019 12:30 PM UTC